Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Conditions:   Neuroendocrine Carcinomas;   Neuroendocrine Tumors;   Carcinoma, Neuroendocrine;   Carcinoma, Adrenocortical;   Carcinoma, Adrenal Cortical Intervention:   Drug: ADCT-701 Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials